KROS
NASDAQ · Biotechnology

Keros Therapeutics Inc

Biotech Stocks Healthcare Stocks
$10.07
-0.15 (-1.47%)
As of Aug 8, 1:52 AM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 9 64%
Hold 5 36%
Sell 0 0%
Price Target
Analyst Price Target +95.6% upside
Low Target $13.49
Average Target $19.70
High Target $20.36
Current Price $10.07
Current
$10.07
Target
$19.70
$13.49 $19.70 avg $20.36
Scenario Analysis
Bear Case
$13.49
34.0%
Low target
Base Case
$19.70
+95.6%
Avg target
Bull Case
$20.36
+102.2%
High target
Risk/Reward
3.0x
Highly favorable
Price in Context
52-Week High
$22.55
-55.3% from high
52-Week Low
$9.69
+3.9% from low
Target vs 52W High
$19.70
-12.6% vs high
Next Earnings Report
Aug 12, 2026 · Before Market Open
3d
until earnings
EPS Est: $-1.37
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%